{"entity":{"type":"insider","cik":"0001266125","url":"/insider/0001266125","json_url":"/insider/0001266125.json","name":"BRISTOW MICHAEL R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":19,"first":"2005-08-19","last":"2017-04-05","span_basis":"filed_date"},"name_variants":[{"name":"BRISTOW MICHAEL R","source":"filing","n_filings":19,"first_seen":"2005-08-19","last_seen":"2017-04-05"}],"transactions":[{"id":4562664,"accession":"0001209191-17-025617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-025617","line_url":"/filing/0001209191-17-025617#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Pres. & Chief Executive Offic)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & Chief Executive Offic","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":720.0,"shares_display":"720","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":1735.2,"total_display":"1,735.20","total_whole":"1,735","shares_owned_after":41155.0,"shares_owned_after_display":"41,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider"},{"id":5156554,"accession":"0001209191-17-015978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-015978","line_url":"/filing/0001209191-17-015978#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Pres. & Chief Executive Offic)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & Chief Executive Offic","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":763.0,"shares_display":"763","price_per_share":2.61,"price_display":"2.61","price_state":"stated","total_value":1991.43,"total_display":"1,991.43","total_whole":"1,991","shares_owned_after":41875.0,"shares_owned_after_display":"41,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":3257959,"accession":"0001209191-16-142261","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-142261","line_url":"/filing/0001209191-16-142261#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Pres. & Chief Executive Offic)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & Chief Executive Offic","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1972.0,"shares_display":"1,972","price_per_share":2.89,"price_display":"2.89","price_state":"stated","total_value":5699.08,"total_display":"5,699.08","total_whole":"5,699","shares_owned_after":42638.0,"shares_owned_after_display":"42,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-21","scope":"insider"},{"id":2814115,"accession":"0000899243-16-017729","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-017729","line_url":"/filing/0000899243-16-017729#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":724.0,"shares_display":"724","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":2548.48,"total_display":"2,548.48","total_whole":"2,548","shares_owned_after":44610.0,"shares_owned_after_display":"44,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-05","filed_date":"2016-04-06","scope":"insider"},{"id":2640042,"accession":"0000899243-16-014985","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-014985","line_url":"/filing/0000899243-16-014985#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":752.0,"shares_display":"752","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":2632.0,"total_display":"2,632.00","total_whole":"2,632","shares_owned_after":45334.0,"shares_owned_after_display":"45,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-02","scope":"insider"},{"id":8170095,"accession":"0000899243-15-005097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-005097","line_url":"/filing/0000899243-15-005097#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1809.0,"shares_display":"1,809","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":11450.97,"total_display":"11,450.97","total_whole":"11,451","shares_owned_after":46086.0,"shares_owned_after_display":"46,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-18","filed_date":"2015-09-21","scope":"insider"},{"id":8792628,"accession":"0001209191-15-020302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-020302","line_url":"/filing/0001209191-15-020302#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5446.0,"shares_display":"5,446","price_per_share":0.7131,"price_display":"0.71","price_state":"stated","total_value":3883.5426,"total_display":"3,883.54","total_whole":"3,884","shares_owned_after":335279.0,"shares_owned_after_display":"335,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-02","scope":"insider"},{"id":6384961,"accession":"0001209191-14-058829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-058829","line_url":"/filing/0001209191-14-058829#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13853.0,"shares_display":"13,853","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":18008.9,"total_display":"18,008.90","total_whole":"18,009","shares_owned_after":292625.0,"shares_owned_after_display":"292,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-18","filed_date":"2014-09-19","scope":"insider"},{"id":4842065,"accession":"0001209191-13-004660","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-004660","line_url":"/filing/0001209191-13-004660#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1069290.0,"shares_display":"1,069,290","price_per_share":0.4676,"price_display":"0.47","price_state":"stated","total_value":500000.004,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":1069290.0,"shares_owned_after_display":"1,069,290","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-25","filed_date":"2013-01-28","scope":"insider"},{"id":5138512,"accession":"0001209191-06-049071","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-06-049071","line_url":"/filing/0001209191-06-049071","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29602.0,"shares_display":"29,602","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":1036070.0,"total_display":"1,036,070.00","total_whole":"1,036,070","shares_owned_after":29191.0,"shares_owned_after_display":"29,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-09-05","filed_date":"2006-09-06","scope":"insider","n_lines":2},{"id":5325396,"accession":"0001209191-06-048907","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-06-048907","line_url":"/filing/0001209191-06-048907","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56547.0,"shares_display":"56,547","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":1979145.0,"total_display":"1,979,145.00","total_whole":"1,979,145","shares_owned_after":60800.0,"shares_owned_after_display":"60,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-09-01","filed_date":"2006-09-05","scope":"insider","n_lines":2},{"id":9261227,"accession":"0001209191-06-002724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-002724","line_url":"/filing/0001209191-06-002724","is_derivative":false,"issuer_cik":"0001266125","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001266125","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Chief Science & Medical Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":30.117791666666665,"price_display":"30.12","price_state":"stated","total_value":903533.75,"total_display":"903,533.75","total_whole":"903,534","shares_owned_after":65800.0,"shares_owned_after_display":"65,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-03","filed_date":"2006-01-09","scope":"insider","n_lines":3},{"id":4834877,"accession":"0001209191-06-001713","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-06-001713","line_url":"/filing/0001209191-06-001713","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Chief Science & Medical Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":30.117791666666665,"price_display":"30.12","price_state":"stated","total_value":903533.75,"total_display":"903,533.75","total_whole":"903,534","shares_owned_after":65800.0,"shares_owned_after_display":"65,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-03","filed_date":"2006-01-04","scope":"insider","n_lines":3},{"id":1534020,"accession":"0001209191-05-063033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-063033","line_url":"/filing/0001209191-05-063033","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Chief Science & Medical Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":28.0498,"price_display":"28.05","price_state":"stated","total_value":1682988.0,"total_display":"1,682,988.00","total_whole":"1,682,988","shares_owned_after":77000.0,"shares_owned_after_display":"77,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-12","filed_date":"2005-12-13","scope":"insider","n_lines":2},{"id":1641173,"accession":"0001209191-05-060884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-060884","line_url":"/filing/0001209191-05-060884#line-2","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Chief Science & Medical Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.673,"price_display":"20.67","price_state":"stated","total_value":206730.0,"total_display":"206,730.00","total_whole":"206,730","shares_owned_after":105800.0,"shares_owned_after_display":"105,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-01","filed_date":"2005-12-02","scope":"insider"},{"id":1282674,"accession":"0001209191-05-055443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-055443","line_url":"/filing/0001209191-05-055443#line-2","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Chief Science & Medical Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.635,"price_display":"19.64","price_state":"stated","total_value":196350.0,"total_display":"196,350.00","total_whole":"196,350","shares_owned_after":110800.0,"shares_owned_after_display":"110,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-01","filed_date":"2005-11-03","scope":"insider"},{"id":1484163,"accession":"0001209191-05-050724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-050724","line_url":"/filing/0001209191-05-050724#line-2","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Chief Science & Medical Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":23.664,"price_display":"23.66","price_state":"stated","total_value":236640.0,"total_display":"236,640.00","total_whole":"236,640","shares_owned_after":115800.0,"shares_owned_after_display":"115,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-03","filed_date":"2005-10-04","scope":"insider"},{"id":1504451,"accession":"0001209191-05-045560","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-05-045560","line_url":"/filing/0001209191-05-045560","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Chief Science & Medical Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.188,"price_display":"20.19","price_state":"stated","total_value":201880.0,"total_display":"201,880.00","total_whole":"201,880","shares_owned_after":120800.0,"shares_owned_after_display":"120,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-01","filed_date":"2005-09-01","scope":"insider","n_lines":3},{"id":1647723,"accession":"0001209191-05-043768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-043768","line_url":"/filing/0001209191-05-043768#line-2","is_derivative":false,"issuer_cik":"0001101052","issuer_name":"MYOGEN INC","issuer_ticker":"MYOG","issuer_name_source":null,"issuer_url":"/issuer/0001101052","owner_cik":"0001266125","owner_name":"BRISTOW MICHAEL R","owner_display_name":"BRISTOW MICHAEL R","owner_url":"/insider/0001266125","role":"Director, Officer (Chief Science & Medical Off)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science & Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.83,"price_display":"20.83","price_state":"stated","total_value":208300.0,"total_display":"208,300.00","total_whole":"208,300","shares_owned_after":125800.0,"shares_owned_after_display":"125,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-08-18","filed_date":"2005-08-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":27,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"ARCA biopharma, Inc.","url":"/issuer/0000907654","role":"Director, Officer (Pres. & Chief Executive Offic), Ten percent owner","n_filings":9,"first_seen":"2013-01-28","last_seen":"2017-04-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001101052","name":"MYOGEN INC","url":"/issuer/0001101052","role":"Director, Officer (Chief Science & Medical Off)","n_filings":10,"first_seen":"2005-08-19","last_seen":"2006-09-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001266125","retrieved_at":"2026-08-24T02:15:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}